Public company
Inhibikase Therapeutics, Inc.
IKTCIK 0001750149
Price$1.50
1 year-11.8%
Disclosed transactions1
Buys / sells1 / 0
Max Insider Score42
Connections with evidence4
IKT · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 42 | Sands Capital Life Sciences Pulse Fund II, L.P.10% Owner | IKTInhibikase Therapeutics, Inc. Open-market purchase | BUY | $3.00M 2.07M sh |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 5, 2026
- ← Insider ofevidenceSands Capital Life Sciences Pulse Fund II, L.P.10% Owner · Nov 24, 2025
- ← Insider ofevidenceSands Capital Alternatives, LLC10% Owner · Nov 24, 2025
- ← Insider ofevidenceSands Frank M.10% Owner · Nov 24, 2025